臨床薬理の進歩 No.44
156/235

20)Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional Esophageal Disorders. Gastroenterology 2016; S0016-5085(16): 00178-5. 21)Hungin APS, Scarpignato C, Keefer L, Corsetti M, Anastasiou F, Muris JWM, et al. Review article: rethinking the “ladder” approach to reflux-like symptom management in the era of PPI “resistance” - a multidisciplinary perspective. Aliment Pharmacol Ther 2022; 55(12): 1492–500.14218)Vaezi MF, Katzka D, Zerbib F. Extraesophageal symptoms and diseases attributed to GERD: Where is the pendulum swinging now? Clin Gastroenterol Hepatol 2018; 16(7): 1018–29. 19)Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest 2013; 143(3): 605–12.

元のページ  ../index.html#156

このブックを見る